May 8, 2018 – CRF faculty member, Roxana Mehran, MD, was presented with the Excellence in Medical Leadership Award during the 18th Annual Wenger Awards in Washington, DC on Monday, May 7, 2018. The annual awards ceremony organized by WomenHeart is named after Nanette K. Wenger, MD, a pioneer in women’s cardiology, and recognizes individuals and organizations for their extraordinary contributions to women’s heart health.

Roxana Mehran, MD, is a Course Co-Director of Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of CRF. She is also Professor of Medicine at Mount Sinai School of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Wiener Cardiovascular Institute.

Dr. Mehran is internationally renowned for her work as a clinical trial specialist with complex data analyses and outcomes research within the field of interventional cardiovascular medicine. She currently serves on the board of trustees of the Society for Cardiovascular Angiography and Interventions (SCAI) and is a member of the Program Committee for the American Heart Association Scientific Sessions. She is also the co-founder and Program Chair of SCAI's Women in Innovations (WIN), a global initiative aimed at creating and strengthening research, educational, and professional opportunities for female interventional cardiologists. 

New York, NY – March 7, 2018 – Staff and fellows from the Cardiovascular Research Foundation (CRF) will be presenting at the American College of Cardiology’s 67th Annual Scientific Session taking place March 10-12, 2018 at the Orange County Convention Center in Orlando, FL. They will be presenting the latest data on percutaneous coronary intervention (PCI), drug-eluting stents, imaging technologies, plaque morphology, and transcatheter aortic valve replacement.

CRF will also host a satellite program on complex PCI prior to the start of ACC on Friday, March 9, 6:30 PM – 9:00 PM called CHIP at ACC.18: The Interventional Toolbox for Complete Revascularization in Higher-Risk (and Indicated) Patients at the Hilton Orlando (Orange Ballroom D, Lower Level). Presentations will address treatment of left main coronary artery disease, chronic total occlusions, bifurcation lesions, severe calcification, and depressed ventricular function. Expert faculty will offer insights into selecting appropriate patients for coronary revascularization and optimizing technique.

As part of its commitment to mentoring the next generation of researchers, CRF teaches and develops interventional cardiology fellows from all over the world through its prestigious fellowship program. Poster abstracts from CRF staff and fellows include:

1111-229/229 - Outcomes of Patients With Small Vessels Undergoing PCI With Contemporary Drug-Eluting Stents: A Sub-Analysis From the BIONICS Study

Maayan Konigstein

Saturday, March 10, 2018, 10:00 AM - 10:45 AM; Poster Hall, Hall A/B

1115-268/268 - Relationship Between Underlying Plaque Morphology Evaluated by Near-Infrared Spectroscopy and the Degree of Coronary Artery Stenosis: The COLOR Registry

Masaru Ishida

Saturday, March 10, 2018, 10:00 AM - 10:45 AM; Poster Hall, Hall A/B

1115-277/277 - Clinical Predictors of Culprit Lesion Lipid Quantified by Near Infrared Spectroscopy: Insights From the COLOR Registry

Akiko Fujino

Saturday, March 10, 2018, 10:00 AM - 10:45 AM; Poster Hall, Hall A/B

1155-280/280 - Prevalence and Predictors of Long-Term Target Vessel and Non-Target Vessel Myocardial Infarction After PCI: A Patient Level Analysis Integrating Data From 12 Clinical Trials

Yuqi Fan

Saturday, March 10, 2018, 3:45 PM - 4:30 PM; Poster Hall, Hall A/B

1198-272/272 - Angiographic Predictors of Lipid Rich Plaque Detected by Near-Infrared Spectroscopy: The COLOR Registry

Mitsuaki Matsumura

Sunday, March 11, 2018, 9:45 AM - 10:30 AM; Poster Hall, Hall A/B

1198-278/278 - Intravascular Ultrasound Mechanisms of In-Stent Restenosis in Saphenous Vein Graft Lesions

Rafal Wolny

Sunday, March 11, 2018, 9:45 AM - 10:30 AM; Poster Hall, Hall A/B

1244-235/235 - Assessment of Proximal Left Anterior Descending Artery Size by Intravascular Ultrasound For Optimal Stent Sizing

Evan Shlofmitz

Sunday, March 11, 2018, 3:45 PM - 4:30 PM; Poster Hall, Hall A/B

1244-237/237 - Characteristics and Distribution of Calcium in the Distal Left Main Bifurcation Assessed by Optical Coherence Tomography

Song-Yi Kim

Sunday, March 11, 2018, 3:45 PM - 4:30 PM; Poster Hall, Hall A/B

1246-290/290 - Reduced Baseline Ejection Fraction Is Associated With Increased Cardiovascular Mortality After Transcatheter Aortic Valve Replacement: Results From the PARTNER II Trials

Ariel Furer

Sunday, March 11, 2018, 3:45 PM - 4:30 PM; Poster Hall, Hall A/B

1285-229/229 - Safety of Same-Day Discharge After Percutaneous Coronary Intervention With Orbital Atherectomy

Evan Shlofmitz

Monday, March 12, 2018, 9:45 AM - 10:30 AM; Poster Hall, Hall A/B

1290-300/300 - Outcomes of Diabetic Patients Undergoing PCI With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Study

Maayan Konigstein

Monday, March 12, 2018, 9:45 AM - 10:30 AM; Poster Hall, Hall A/B

1292-310/310 - Predictors of Left Main Coronary Artery Stent Dimensions: An EXCEL Trial Intravascular Ultrasound Substudy

Akiko Fujino

Monday, March 12, 2018, 9:45 AM - 10:30 AM; Poster Hall, Hall A/B

1320M-03 - Impact of Small Device Use in the Proximal LAD Versus Other Coronary Segments on Long-Term Clinical Outcomes: An ADAPT-DES Sub-Analysis

Evan Shlofmitz

Monday, March 12, 2018, 12:30 PM - 12:40 PM; Interventional Cardiology Moderated Poster Theater, Poster Hall, Hall A/B

1320M-07 - Incidence and Predictors of Contemporary DES Failure: Individual-Patient Data Pooled Analysis From 11 Randomized Controlled Trials

Maayan Konigstein

Monday, March 12, 2018, 1:00 PM - 1:10 PM; Interventional Cardiology Moderated Poster

Theater, Poster Hall, Hall A/B

To learn more about CRF’s research and educational programs at ACC.18, visit Booth #3035.

CRF’s 30th Annual Scientific Symposium Will Take Place September 21-25 in San Diego

WHAT:

Media registration is now open online for TCT 2018 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine, attracting more than 10,000 attendees from 90 countries all over the world.

Every year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the globe to present and discuss the latest evidence-based research in the field.  TCT will also be celebrating 30 years of groundbreaking science, training and innovation by featuring an expanded emphasis on practical sessions and training workshops where clinicians will gain new skills to apply to their practice to improve patient outcomes.

WHEN:

September 21-25, 2018

Agenda Highlights

WHERE:

San Diego Convention Center

San Diego, CA

WHY:

Heart disease remains the leading cause of death worldwide. Every year, the discoveries made through hundreds of studies and late breaking trials presented at TCT lead to advancements in new medicines and devices that ultimately lead to improved care for people with heart disease.

HOW TO REGISTER:

Media may apply for registration by visiting:     

http://www.crf.org/tct/press/press-registration-form

Details on required press credentials can be found at:

http://www.crf.org/tct/press/press-credentials-and-guidelines

New York, NY – March 6, 2018 – Leading interventional cardiology experts from the Cardiovascular Research Foundation (CRF) will be presenting at the American College of Cardiology’s 67th Annual Scientific Session taking place March 10-12, 2018 at the Orange County Convention Center in Orlando, FL. Below is a list of presentations as well as top experts available for comment on research being presented at this year’s meeting.

Presentations

615-08 Left Main Disease- NOBLE, EXCEL, Now What?

Hybrid Coronary Revascularization: Where Did It Go or Is It Here to Stay?

Gregg W. Stone, MD

Saturday, March 10, 2018, 12:25 PM - 12:35 PM; Room 204C

903-08 - Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study

Highlighted Original Research: Interventional Cardiology and the Year in Review

Ajay J. Kirtane, MD

Sunday, March 11, 2018, 8:38 AM - 8:48 AM; Room 204C

 

Experts Available for Comment

Gregg W. Stone, MD is Professor of Medicine at the Columbia University Medical Center, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at New York-Presbyterian Hospital, and Co-Director of Medical Research and Education at the Cardiovascular Research Foundation. Dr. Stone has served as the national or international principal investigator for approximately 100 national and international multicenter randomized trials (many of which have led to new device approval or indications in the U.S.), has authored more than 2,000 manuscripts and abstracts published in peer-reviewed literature as well as numerous book chapters, and has delivered thousands of invited lectures around the world. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter mitral valve repair and replacement; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; new device angioplasty including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; left atrial appendage closure; contrast nephropathy; clinical trial design; and regulatory issues.

Juan F. Granada, MD, is the President and Chief Executive Officer of the Cardiovascular Research Foundation (CRF). A renowned leader in cardiology, he joined CRF in 2007 and served as Executive Director and Chief Innovation Officer at the CRF Skirball Center for Innovation, the preclinical division of CRF. He is also an Assistant Professor of Medicine at Columbia University College of Physicians and Surgeons. Dr. Granada is one of the world’s foremost investigators in the translational validation of novel cardiovascular therapies and has helped develop and successfully validate several endovascular imaging and device technologies.  

Ori Ben-Yehuda, MD, is Executive Director of the CRF Clinical Trials Center (CTC) and an experienced cardiologist and co-author of numerous scientific publications in top tier medical journals. He has been a clinical researcher for two decades and is the Deputy Editor of Structural Heart: The Journal of the Heart Team. He was formerly Deputy Editor of the Journal of the American College of Cardiology from 2002 through 2010.

Ajay J. Kirtane, MD, SM, is Associate Professor of Medicine at Columbia University Medical Center and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian Hospital/Columbia University Medical Center. He is also co-director of CRF’s Transcatheter Cardiovascular Therapeutics meeting. Dr. Kirtane is a practicing cardiologist with an interest in coronary and peripheral intervention. His research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in interventional cardiology. He has authored or co-authored more than 150 original manuscripts and over 50 reviews and chapters including the “Coronary Stenting” chapters of the two most widely used textbooks in interventional cardiology. He has been principal investigator for several multicenter trials of interventional devices and serves on the steering committees of several large-scale clinical trials in interventional cardiovascular medicine.

To learn more about CRF’s research and educational programs at ACC.18, visit Booth #3035.

Subcategories

1 2 1